NCT05768776Active, not recruiting
Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology
To Compare the Effectiveness of the MOSES 2.0 Technology to the Non-MOSES Technology on the Success Rate of Holmium LASER Enucleation of the Prostate (HoLEP) Performed on an Outpatient Basis in the Context of Benign Prostatic Hypertrophy.
Source: ClinicalTrials.gov · Last updated 25 Jun 2025
Brief summary (registry, in English)
The aim of this study is to compare the success rate of outpatient surgery after holmium LASER enucleation of the prostate (HoLEP) for the treatment of BPH with and without the use of the MOSES 2.0 effect.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 3 Mar 2023
- Start date
- 28 Jun 2023
- Primary completion date
- Jul 2025
- Lead sponsor
- University Hospital, Bordeaux
- NCT number
- NCT05768776
What you commit to
- Study type: Observational
- Planned participants: 200
- From 28 Jun 2023 to the primary completion date, Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of BPH surgery
- History of prostate cancer
- Existence or history of urethral stricture
Other
- Inability to read or write French
- Patients with comorbidities contraindicating general anesthesia
- Patients not eligible for outpatient care according to French recommendations (high risk of complications after general anesthesia, place of residence more than 150 km from an emergency department, alone at home the night following the intervention) .
- Preoperative prostate volume measured by ultrasound (suprapubic or transrectal) \< 40g
- Existence or suspicion of a "neurological" bladder
- Positive preoperative cytobacteriological examination not treated appropriately
- Adult patients subject to a legal protection measure or unable to express their consent
- Patients deprived of liberty by a judicial or administrative decision or hospitalized without consent or admitted to a health or social establishment for purposes other than research
Who the study is looking for
- Subject over 50 years old
- BPH whose symptoms require surgical management
- Preoperative prostate volume measured by ultrasound (suprapubic or transrectal) ≥ 40g
- IPSS score \> 15 and Quality of Life score ≥ 3
- Maximum urinary output (Qmax) \< 15 ml/sec
Age in the registry: 50 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Bordeaux Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.